Why is Brooks Lab. falling/rising?

As of 17-Jul, Brooks Laboratories Ltd is experiencing a price increase, currently at 159.75, reflecting a rise of 2.7 or 1.72%. The stock has shown strong performance recently, gaining 14.43% over the last seven days and outperforming its sector by 1.3% today. It is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating positive momentum. Additionally, the stock has generated impressive returns of 92.01% over the past year and 97.65% over the last three years, although it has faced challenges with a weak long-term fundamental strength, as evidenced by a negative Return on Equity (ROE) of -10.2 and declining net sales over the past five years.
In the broader market context, Brooks Laboratories Ltd has significantly outperformed the Sensex in the short term, with a 10.06% increase over the past week compared to a decline of 1.12% in the benchmark index. This strong performance contrasts with the company's year-to-date return of -13.63%, which underlines the volatility and mixed performance over different time frames. While the stock has shown remarkable gains recently, concerns about its long-term fundamentals, including a poor EBIT to Interest ratio and a high Price to Book Value, suggest that investors should remain cautious despite the current upward trend.